These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2811579)

  • 1. [Ursodeoxycholic acid lowers liver enzymes].
    Leuschner U
    Leber Magen Darm; 1989 Sep; 19(5):276. PubMed ID: 2811579
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
    Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
    Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.
    Osuga T; Tanaka N; Matsuzaki Y; Aikawa T
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):49S-51S. PubMed ID: 2574657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ursodeoxycholic acid therapy in biliary cirrhosis].
    Herszényi L; Szalay L; Schaff Z; Gergely P; Fehér J
    Orv Hetil; 1993 Sep; 134(38):2085-9. PubMed ID: 8414454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK; Salen G; Abroon J
    Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
    Podda M; Ghezzi C; Battezzati PM; Crosignani A; Zuin M; Roda A
    Gastroenterology; 1990 Apr; 98(4):1044-50. PubMed ID: 1968871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for chronic liver diseases.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid].
    Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
    Fortschr Med; 1988 Nov; 106(34):691-4. PubMed ID: 3061911
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of chronic liver disease with ursodeoxycholic acid.
    Guslandi M
    J Int Med Res; 1990; 18(6):497-505. PubMed ID: 2292332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study.
    Rolandi E; Franceschini R; Cataldi A; Cicchetti V; Carati L; Barreca T
    Eur J Clin Pharmacol; 1991; 40(5):473-6. PubMed ID: 1679391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bile acid therapy; new hope for patients with chronic liver diseases].
    van Berge Henegouwen GP; van Erpecum KJ
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):696-700. PubMed ID: 2038392
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
    Leuschner U; Fischer H; Hübner K
    Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects in therapeutic use of ursodeoxycholic acid].
    Held C
    Z Arztl Fortbild (Jena); 1990; 84(5):199-201. PubMed ID: 2197822
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of combination therapy of vitamin K1 and ursodeoxycholic acid on liver function tests.
    Iijima T; Nambu M
    Trop Gastroenterol; 1988; 9(3):139-44. PubMed ID: 3194959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ursodeoxycholic acid in primary biliary cirrhosis. 2: Prospective long-term study of 21 patients].
    Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
    Fortschr Med; 1988 Nov; 106(34):695-8. PubMed ID: 3145247
    [No Abstract]   [Full Text] [Related]  

  • 17. [No complaints, but constantly elevated cholestatic serum liver tests].
    Kherbèche H
    Praxis (Bern 1994); 2011 Jul; 100(14):865-7. PubMed ID: 21732301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis.
    Simko V; Michael S; Prego V
    Am J Gastroenterol; 1994 Mar; 89(3):392-8. PubMed ID: 8122652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.